Global Genital Herpes Treatment Market Opportunities & Forecast (2018-2025)-GMI Research

Global Genital Herpes Treatment Market By Drug Type (Acyclovir, Valacyclovir, and Famciclovir), By Route of Administration (Oral, Topical and Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Pharmacies, and Drug Stores) and by Geography – Opportunities & Forecast, 2018-2025

Genital herpes is a sexually transmitted disease which is caused by a viral pathogen, herpes simplex virus (HSV) which is carried out via infected people’s semen, saliva, and vaginal secretions.HSV-1 and HSV-2 are two types of herpes simplex viruses. The common symptoms of genital herpes are blisters on genital organs, itchiness or tingling in the infected areas, pelvic pain, vaginal discharge, etc. Various types of genital herpes treatments are medication, episodic treatment, and suppressive treatment, etc. Antiviral drugs such as Acyclovir, Famciclovir, and Valacyclovir are commercially available drugs that are used for the treatment genital herpes.

Request Sample Pages : https://tinyurl.com/y8o7dl5d

Increasing prevalence of sexually transmitted disease especially genital herpes across the globe is expected to boost the demand of genital herpes treatment over the forecast period. For instance, according to center for disease control and prevention approximately 50.0 million population affected with genital herpes in the U.S. Factors such as rising diagnosis rate in emerging countries and increasing clinical trial of vaccines for genital herpes are also driving the growth of the genital herpes market during the forecast period.

Moreover, increasing awareness about sexually transmitted diseases and rise in government funding to develop innovative therapeutic for the genital herpes treatment spur the market growth during the forecast period. In addition, Accurate diagnostic tests such as competitive polymerase chain reactions (PCR), DNA enzyme immunoassay hybridization, real-time PCR assay are extensively used to diagnose STIs in developed countries. These tests are useful for the diagnosis of asymptomatic infections which would increase the demand for genital herpes treatment and drive the market. However, inadequate reimbursement and low treatment seeking rate for genital herpes, are some of the factors which hinder the growth of the market.

Various notable players operating in the market, include Novartis AG, GlaxoSmithKline, Genocea Biosciences, AiCuris, Vical, Maruho, Teva Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.,, Apotheca Inc., Sandoz Inc., Hospira Inc., Novopharm Ltd., Dr. Reddy’s Laboratories Ltd .among others. Major players are focussing research and development activities to launch innovative therapeutic for the treatment of genital herpes. For instance, GEN-003 vaccines are currently under phase 3 of a clinical trial for the treatment of genital herpes infections.

The global genital herpes treatment market has been segmented on the basis of drug type, route of administration, distribution channel and key geographies. Based on drug type, the market comprises Acyclovir, Valacyclovir, and Famciclovir. The research report “global genital herpes treatment market” provides in-depth analysis of global genital herpes treatment market based on drug type, route of administration, distribution channel and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global genital herpes treatment market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:
1- At what pace is genital herpes treatment market growing? What will be the growth trend in the future?
2- What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the genital herpes treatment market?
4- What are the various application areas and how they are poised to grow?

Market Segmentation

By Drug Type
• Acyclovir
• Valacyclovir
• Famciclovir

By Route of Administration
• Oral
• Topical
• Injectable

By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores

By Geography
• North America
As a part of customization
o By Drug Type
o By Route of administration
o By Distribution Channel
o US
o Canada
o Mexico

• Europe
As a part of customization
o By Drug Type
o By Route of administration
o By Distribution Channel
o UK
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Drug Type
o By Route of administration
o By Distribution Channel
o China
o Australia
o India
o Rest of APAC

• ROW
As a part of customization
o By Drug Type
o By Route of administration
o By Distribution Channel
o Brazil
o South Africa
o GCC countries
o Rest of world (remaining countries of the LAMEA region)

Leading market players
• GlaxoSmithKline
• Genocea Biosciences
• Teva Pharmaceuticals Inc.
• Mylan Pharmaceuticals Inc.,
• Apotheca Inc.,
• Sandoz Inc.,
• Novartis AG,
• Hospira Inc.,
• Novopharm Ltd.,
• Dr. Reddy’s Laboratories Ltd.

*Other prominent players in the market which can be profiled as a part of customization:
• AiCuris
• Vical
• Maruho

For Sample Pages & Detailed Report Description Click @ https://www.gmiresearch.com/report/global-genitalh-herpes-treatment-market-opportunities-forecast-drug-type-share-trends-industry-insight.html

Table of Contents (TOC)

1. Executive Summary

2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Geographical Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology

3. Global Genital Herpes Treatment Market – Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Pipeline Analysis
3.4. Epidemiology
3.5. Drivers
3.6. Restraints
3.7. Trends

4. Global Genital Herpes Treatment Market Revenue Forecast till 2025

5. Global Genital Herpes Treatment Market by Drug Type Revenue Forecast till 2025
5.1. Acyclovir
5.2. Valacyclovir
5.3. Famciclovir

6. Global Genital Herpes Treatment Market by Route of Administration Revenue Forecast till 2025
6.1. Oral
6.2. Topical
6.3. Injectable

7. Global Genital Herpes Treatment Market by Distribution Channel Revenue Forecast till 2025
7.1. Hospital Pharmacies
7.2. Retail Pharmacies
7.3. Online Pharmacies
7.4. Drug Stores

8. Global Genital Herpes Treatment Market by Geography Revenue Forecast till 2025
8.1. North America Genital Herpes Treatment Market Revenue Forecast till 2025
8.1.1. North America Genital Herpes Treatment Market by Drug Type (Option 1: 25% customization)
8.1.1.1. Acyclovir
8.1.1.2. Valacyclovir
8.1.1.3. Famciclovir
8.1.2. North America Genital Herpes Treatment Market by Route of Administration
8.1.2.1. Oral
8.1.2.2. Topical
8.1.2.3. Injectable
8.1.3. North America Genital Herpes Treatment Market by Distribution Channel
8.1.3.1. Hospital Pharmacies
8.1.3.2. Retail Pharmacies
8.1.3.3. Online Pharmacies
8.1.3.4. Drug Stores
8.2. Europe Genital Herpes Treatment Market Revenue Forecast till 2025
8.2.1. Europe Genital Herpes Treatment Market by Drug Type (Option 2: 25% customization)
8.2.1.1. Acyclovir
8.2.1.2. Valacyclovir
8.2.1.3. Famciclovir
8.2.2. Europe Genital Herpes Treatment Market by Route of Administration
8.2.2.1. Oral
8.2.2.2. Topical
8.2.2.3. Injectable
8.2.3. Europe Genital Herpes Treatment Market by Distribution Channel
8.2.3.1. Hospital Pharmacies
8.2.3.2. Retail Pharmacies
8.2.3.3. Online Pharmacies
8.2.3.4. Drug Stores
8.3. Asia-Pacific Genital Herpes Treatment Market Revenue Forecast till 2025
8.3.1. Asia-Pacific Genital Herpes Treatment Market by Drug Type (Option 3: 25% customization)
8.3.1.1. Acyclovir
8.3.1.2. Valacyclovir
8.3.1.3. Famciclovir
8.3.2. Asia-Pacific Genital Herpes Treatment Market by Route of Administration
8.3.2.1. Oral
8.3.2.2. Topical
8.3.2.3. Injectable
8.3.3. Asia-Pacific Genital Herpes Treatment Market by Distribution Channel
8.3.3.1. Hospital Pharmacies
8.3.3.2. Retail Pharmacies
8.3.3.3. Online Pharmacies
8.3.3.4. Drug Stores
8.4. Rest of the World Genital Herpes Treatment Market Revenue Forecast till 2025
8.4.1. Rest of the World Genital Herpes Treatment Market by Drug Type (Option 4: 25% customization)
8.4.1.1. Acyclovir
8.4.1.2. Valacyclovir
8.4.1.3. Famciclovir
8.4.2. Rest of the World Genital Herpes Treatment Market by Route of Administration
8.4.2.1. Oral
8.4.2.2. Topical
8.4.2.3. Injectable
8.4.3. Rest of the World Genital Herpes Treatment Market by Distribution Channel
8.4.3.1. Hospital Pharmacies
8.4.3.2. Retail Pharmacies
8.4.3.3. Online Pharmacies
8.4.3.4. Drug Stores

9. Competitive Landscape
9.1. Porter 5 Analysis
9.2. Major players and their key strategies
9.3. Company Share Analysis

10. Company Profiles (Option 5: 25% Customization – Profiles of 5 Additional Companies of your Choice)
10.1. Novartis AG,
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Recent Developments
10.2. Teva Pharmaceuticals Inc.
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Recent Developments
10.3. Genocea Biosciences
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Recent Developments
10.4. GlaxoSmithKline
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Recent Developments
10.5. Genocea Biosciences
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Recent Developments
10.6. Maruho
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Recent Developments
10.7. Dr. Reddy’s Laboratories Ltd.
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Recent Developments
10.8. Hospira Inc.,
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Recent Developments
10.9. Apotheca Inc.,
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Recent Developments
10.10. Mylan Pharmaceuticals Inc.,
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Recent Developments

11. About GMI Research

Buy Report @ https://tinyurl.com/y8o7dl5d

Our Customized Research (Market Intelligence and Competitive Intelligence) Offerings

Our clients rely on us for the range of our services to give them the intelligence they need to act decisively. GMI Research offers in-depth market and competitive intelligence solutions by leveraging its industry knowledge and experience to provide accurate insights with a complete picture of the market and competition. To know more about our product offering click on the below link:

https://www.gmiresearch.com/productservices/marketcompetitiveintelligence.html

Our Company Profile Solution

Company Profiles provide an insight on competitors, customers, and potential suppliers. We at GMI Research understands that the standard or on shelf company profiles provides little help when it comes to business decision making as it doesn’t cover the information required by the clients.

We have developed a range of company profiles solution to meet our client’s specific business requirements irrespective of their role and the industry they operate in. Our company profiles solutions fit into our client’s business requirements because it provides our client’s with a broader choice of profiles:

https://www.gmiresearch.com/productservices/companyprofiles.html

GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition.

GMI Research leverages its industry expertise and experience to identify the industry trends, big opportunities and potential growth areas across industries. Our Syndicated reports provide actionable insights and covers industry trends, market drivers & restraints, macroeconomics factors, market estimates & forecasts, competitive landscape etc. which helps our clients to strengthen its market position by deploying specific strategies and actions that will lead to higher growth.

Level 1, The Chase Carmanhall Road,
Sandyford Industrial Estate,
Dublin D18 Y3X2, Ireland

U.S Office +1 860 881 2270
Europe Office +353 1 442 8820

Email: sales@gmiresearch.com

This release was published on openPR.